MEITAV INVESTMENT HOUSE LTD - NEON THERAPEUTICS INC ownership

NEON THERAPEUTICS INC's ticker is NTGN and the CUSIP is 64050Y100. A total of 45 filers reported holding NEON THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
MEITAV INVESTMENT HOUSE LTD ownership history of NEON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$3,002,000
-28.4%
639,465
-1.5%
0.20%
-14.9%
Q1 2019$4,192,000
+28.4%
648,8780.0%0.24%
+16.3%
Q4 2018$3,264,000
-40.1%
648,8780.0%0.20%
-24.1%
Q3 2018$5,451,000648,8780.27%
Other shareholders
NEON THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
TRV GP III, LLC 9,741,636$25,718,0007.00%
HARVARD MANAGEMENT CO INC 505,871$1,335,0000.21%
ARMISTICE CAPITAL, LLC 1,050,000$2,772,0000.17%
Maven Securities LTD 381,150$1,006,0000.12%
Athanor Capital, LP 547,651$1,446,0000.09%
MONETA GROUP INVESTMENT ADVISORS LLC 102,652$271,0000.03%
TERRIL BROTHERS, INC. 19,300$51,0000.02%
MEEDER ASSET MANAGEMENT INC 5,878$15,0000.00%
ACADIAN ASSET MANAGEMENT LLC 94,908$251,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NEON THERAPEUTICS INC shareholders